Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to see consistent upward momentum in sales. Most recently the company announced two new contracts — one in healthcare and one in higher education, which are both rapidly growing spaces for Knightscope. According to the company, the sales include four additional emergency communication devices along with related services.
The announcement noted that a private California university has added two K1 Blue Light Towers along with a full-service maintenance program to its existing emergency phone system. The order expands access to critical services comprised of 15 total devices located across the campus. “Knightscope’s K1 Blue Light Towers and Blue Light Emergency Phones provide a very noticeable and recognizable fixed location to access dependable communications away from buildings, when a cellphone battery dies or [if] there is simply no service available,” said the company in the press release. “They are fully wireless and don’t require digging or trenching when installed. At the push of a button, a student, guest or teacher may call security for immediate assistance in the event of an emergency.
The second sale comes from Knightscope authorized partner Paramount Security Partners, which sold two solar-powered K1 Blue Light E-Phones to a well-known, New-Jersey-based teaching hospital and biomedical research facility. One of the largest healthcare providers in the region, the facility reports more than 1.2 million outpatient visits every year, with 7,000-plus employees on the campus. “Following Knightscope’s recommendations for securing medical facilities, clients have been deploying the company’s technologies to keep healthcare workers and patients safe and to prevent minor issues from becoming major issues,” said the company in the press release.
To view the full press release, visit https://ibn.fm/M5u80
About Knightscope, Inc.
Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.
NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBNInvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Provides Interim Analysis from Phase 1b NGC-Cap Trial
